We are pleased to share the news that Dr Jan Petracek, PrimeVigilance CEO and a leading expert in Pharmacovigilance, will be lecturing at the upcoming MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing course held in London on Oct 15 – 19, 2018.

Signal Management in the European Union will be the key topic of his lectures, which aim to benefit professionals with basic knowledge and experience in #Pharmacovigilance or adjacent functions, such as PV Officers, PV Specialists, PV Experts, PV Coordinators, and Heads/Directors/Managers of Regulatory Compliance, Quality or Safety departments.

If you fall into any of these categories and would like more information please visit the DIA website for a detailed agenda and registration details.

If you are interested in an on-site  meeting with Dr. Petracek or have any other questions, please let us know by contacting us directly at marketing@primevigilance.com .

The 5 days of training include a comprehensive overview of the core processes and systems in place and the latest news on the international harmonisation and standardisation activities in pharmacovigilance. Now available in individual Modules.

Share this:




This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Cookie Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

  • __cfduid

Decline all Services
Accept all Services